Skip to main content

Table 2 Comparison of fracture characteristics and healthcare resource utilization between groups (follow-up period; overall study group)

From: Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database

 

Unadjusted

Matched

Characteristic

All (N = 15,559)

T2DM (N = 7580)

Non-DM (N = 7979)

P value

All (N = 6546)

T2DM (N = 3273)

Non-DM (N = 3273)

P value

Fractures

 Patients with clinical fracturesa, n (%)

1882 (12.1)

1029 (13.6)

853 (10.7)

<0.001

738 (11.3)

415 (12.7)

323 (9.9)

<0.001

 Number of days to first fracture, mean (SD)

442.8 (259.0)

443.4 (257.7)

442.2 (260.6)

<0.0001b

454.5 (261.8)

455.5 (259.2)

453.3 (265.5)

0.0003b

 Patients with non-vertebral fractures, n (%)

1454 (9.3)

817 (10.8)

637 (8.0)

<0.001

565 (8.6)

329 (10.1)

236 (7.2)

<0.001

Resource utilization

 BMD test, n (%)

6633 (42.6)

2739 (36.1)

3894 (48.8)

<0.001

2726 (41.6)

1271 (38.8)

1455 (44.5)

<0.001

 Bone formation test, n (%)

768 (4.9)

384 (5.1)

384 (4.8)

0.466

279 (4.3)

135 (4.1)

144 (4.4)

0.582

 Bone resorption test, n (%)

1535 (9.9)

634 (8.4)

901 (11.3)

<0.001

609 (9.3)

278 (8.5)

331 (10.1)

0.024

 Osteoporosis-related testsc (post-baseline), n (%)

11,454 (73.6)

5594 (73.8)

5860 (73.4)

0.614

4748 (72.5)

2430 (74.2)

2318 (70.8)

0.002

 Osteoporosis-related testsc (post-baseline), mean per patient (SD)

2.873 (3.198)

2.994 (3.369)

2.758 (3.022)

<0.001

2.719 (3.057)

2.86 (3.118)

2.578 (2.989)

<0.001

 Hospital admissions, n (%)

4799 (30.8)

2980 (39.3)

1819 (22.8)

<0.001

1941 (29.7)

1177 (36.0)

764 (23.3)

<0.001

 Hospital admissions, mean per patient (SD)

0.585 (1.451)

0.776 (1.646)

0.405 (1.212)

<0.001

0.515 (1.46)

0.635 (1.687)

0.395 (1.179)

<0.001

 Days in hospital, mean (SD)

11.58 (36.23)

16.02 (44.22)

7.366 (25.8)

<0.001

9.622 (30.03)

12.33 (34.71)

6.914 (24.16)

<0.001

 Outpatient visits, n (%)

15,511 (99.7)

7561 (99.7)

7950 (99.6)

0.205

6529 (99.7)

3270 (99.9)

3259 (99.6)

0.008

 Outpatient visits, mean per patient (SD)

39.52 (54.6)

46.84 (58.98)

32.56 (49.09)

<0.001

36.26 (45.97)

40.06 (45.13)

32.45 (46.5)

<0.001

 Laboratory tests, n (%)

3010 (19.3)

1645 (21.7)

1365 (17.1)

<0.001

1338 (20.4)

762 (23.3)

576 (17.6)

<0.001

 Laboratory tests, mean per patient (SD)

52.11 (182.8)

68.84 (215.1)

36.21 (144)

<0.001

47.56 (157.9)

57.57 (167.1)

37.54 (147.5)

<0.001

 Total cost in JPY, mean (SD)

1,130,000 (2,390,000)

1,490,000 (2,750,000)

782,000 (1,940,000)

<0.001

912,000 (1,860,000)

1,080,000 (1,930,000)

743,000 (1,770,000)

<0.001

 Total cost in JPY, median

322,000

517,000

209,000

 

295,000

401,000

219,000

<0.001d

  1. Abbreviations: BMD bone mineral density, DM diabetes mellitus, JPY Japanese Yen, SD standard deviation, T2DM type 2 diabetes mellitus
  2. aClinical fractures include vertebral and non-vertebral fractures
  3. bP value from Log Rank test
  4. cOsteoporosis-related tests include bone formation tests, bone resorption tests, imaging tests, and BMD measurements
  5. dP value from Wilcoxon Rank Sum test